Eribulin

Eribulin is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin is primarily used in the treatment of metastatic breast cancer. It may also be used for other types of cancer as determined by a healthcare provider. The drug is administered intravenously and targets cancer cells to inhibit their growth.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients may experience fever, constipation, or peripheral neuropathy. These effects can vary widely among individuals.

Eribulin should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines and monitor for any adverse reactions. Pregnant women and those with certain medical conditions should consult their healthcare provider before use.

Eribulin may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the drug's efficacy.